Adjuvant treatment with secukinumab induced long term remission in a patient with severe bullous pemphigoid.

Holtsche, Maike Marleen; Hammers, Christoph Matthias; Chakievska, Lenche; Ludwig, Ralf Joachim; Thaci, Diamant; Zillikens, Detlef; Schmidt, Enno

Holtsche, Maike Marleen; Hammers, Christoph Matthias; Chakievska, Lenche; Ludwig, Ralf Joachim; Thaci, Diamant; Zillikens, Detlef; Schmidt, Enno.

Afiliación

Holtsche MM; Department of Dermatology, University of Lübeck, Lübeck, Germany.
Hammers CM; Department of Dermatology, University of Lübeck, Lübeck, Germany.
Chakievska L; Lübeck Institute for Experimental Dermatology (LIED), University of Lübeck, Lübeck, Germany.
Ludwig RJ; Lübeck Institute for Experimental Dermatology (LIED), University of Lübeck, Lübeck, Germany.
Thaci D; Institute for Inflammation Medicine, University of Lübeck, Lübeck, Germany.
Zillikens D; Department of Dermatology, University of Lübeck, Lübeck, Germany.
Schmidt E; Department of Dermatology, University of Lübeck, Lübeck, Germany.

J Dtsch Dermatol Ges ; 18(12): 1478-1480, 2020 Dec.

Article en En | MEDLINE | ID: mdl-32975029

Asunto(s)

Penfigoide Ampolloso; Adyuvantes Inmunológicos; Anticuerpos Monoclonales Humanizados; Azatioprina; Humanos; Penfigoide Ampolloso/tratamiento farmacológico

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Penfigoide Ampolloso Límite: Humans Idioma: En Revista: J Dtsch Dermatol Ges Asunto de la revista: DERMATOLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Alemania

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google